PDS Biotechnology Corp Gain (Loss) on Disposition of Assets
PDS Biotechnology Corp (PDSB) reported Gain (Loss) on Disposition of Assets of -$979.27 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2020-03-27
- PDS Biotechnology Corp gain (loss) on disposition of assets for the quarter ending 2019-12-31 was -$34.83K.
- PDS Biotechnology Corp gain (loss) on disposition of assets for the quarter ending 2019-09-30 was -$944.45K.
- PDS Biotechnology Corp gain (loss) on disposition of assets for the quarter ending 2018-12-31 was $0.00.
- PDS Biotechnology Corp gain (loss) on disposition of assets for the quarter ending 2018-09-30 was $0.00.
- PDS Biotechnology Corp gain (loss) on disposition of assets for fiscal 2019 was -$979.27K.
- PDS Biotechnology Corp gain (loss) on disposition of assets for fiscal 2018 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$34.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$979.27K derived: sum of 2 quarters · filed 2020-03-27 | -$979.27K 10-K · filed 2020-03-27 | |
| 2019-09-30 | -$944.45K 10-Q · filed 2019-11-07 | -$944.45K 10-Q · filed 2019-11-07 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 derived: sum of 2 quarters · filed 2020-03-27 | $0.00 10-K · filed 2020-03-27 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |